{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:02:49Z","timestamp":1790258569626,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T00:00:00Z","timestamp":1505088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/bmt.2017.191","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T13:41:31Z","timestamp":1505137291000},"page":"1583-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL"],"prefix":"10.1038","volume":"52","author":[{"given":"F","family":"El Chaer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N C","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z N","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Koka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"Rapoport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Emadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,11]]},"reference":[{"key":"BFbmt2017191_CR1","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.","journal-title":"N Engl J Med"},{"key":"BFbmt2017191_CR2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V124.21.796.796","volume":"124","author":"W Stock","year":"2014","unstructured":"Stock W, Luger SM, Advani AS, Geyer S, Harvey RC, Mullighan CG et al. Favorable outcomes for older adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL): early results of U.S. intergroup trial C10403. Blood 2014; 124: 796.","journal-title":"Blood"},{"key":"BFbmt2017191_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","volume":"10","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Mullighan CG, Onciu M, Behm FG, Raimondi SC, Pei D et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol 2009; 10: 147\u2013156.","journal-title":"Lancet Oncol"},{"key":"BFbmt2017191_CR4","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2006-11-056754","volume":"109","author":"DJ DeAngelo","year":"2007","unstructured":"DeAngelo DJ, Yu D, Johnson JL, Coutre SE, Stone RM, Stopeck AT et al. Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. Blood 2007; 109: 5136\u20135142.","journal-title":"Blood"},{"key":"BFbmt2017191_CR5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.bbmt.2012.07.011","volume":"18","author":"M Bakr","year":"2012","unstructured":"Bakr M, Rasheed W, Mohamed SY, Al-Mohareb F, Chaudhri N, Al-Sharif F et al. Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2012; 18: 1897\u20131904.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2017191_CR6","first-page":"1","volume":"3","author":"H Reddy","year":"2016","unstructured":"Reddy H, Duffy A, Holtzman NG, Emadi A . The role of \u03b2-elimination for the clinical activity of hypomethylating agents and cyclophosphamide analogues. American Journal of Cancer Therapy and Pharmacology 2016; 3: 1\u20138.","journal-title":"American Journal of Cancer Therapy and Pharmacology"},{"key":"BFbmt2017191_CR7","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","volume":"106","author":"JM Rowe","year":"2005","unstructured":"Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM et al. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993. Blood 2005; 106: 3760\u20133767.","journal-title":"Blood"},{"key":"BFbmt2017191_CR8","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1182\/blood-2012-09-458570","volume":"122","author":"MP McCormack","year":"2013","unstructured":"McCormack MP, Shields BJ, Jackson JT, Nasa C, Shi W, Slater NJ et al. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL. Blood 2013; 122: 2093\u20132103.","journal-title":"Blood"},{"key":"BFbmt2017191_CR9","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3109\/10428194.2013.856425","volume":"55","author":"B Bhatnagar","year":"2014","unstructured":"Bhatnagar B, Duong VH, Gourdin TS, Tidwell ML, Chen C, Ning Y et al. Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy. Leuk Lymphoma 2014; 55: 1533\u20131537.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt2017191_CR10","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/leu.2009.58","volume":"23","author":"L Y\u00e1nez","year":"2009","unstructured":"Y\u00e1nez L, Berm\u00fadez A, Richard C, Bureo E, Iriondo A . Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia. Leukemia 2009; 23: 1342\u20131343.","journal-title":"Leukemia"},{"key":"BFbmt2017191_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/ajh.23778","volume":"89","author":"MJ Burke","year":"2014","unstructured":"Burke MJ, Lamba JK, Pounds S, Cao X, Ghodke-Puranik Y, Lindgren BR et al. A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed\/refractory acute lymphoblastic leukemia. Am J Hematol 2014; 89: 889\u2013895.","journal-title":"Am J Hematol"},{"key":"BFbmt2017191_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157\u2013163.","journal-title":"Nature"},{"key":"BFbmt2017191_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ng.2913","volume":"46","author":"B Knoechel","year":"2014","unstructured":"Knoechel B, Roderick JE, Williamson KE, Zhu J, Lohr JG, Cotton MJ et al. An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia. Nat Genet 2014; 46: 364\u2013370.","journal-title":"Nat Genet"},{"key":"BFbmt2017191_CR14","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1182\/blood-2011-04-345595","volume":"118","author":"LE Hogan","year":"2011","unstructured":"Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 2011; 118: 5218\u20135226.","journal-title":"Blood"},{"key":"BFbmt2017191_CR15","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3109\/10428194.2015.1110747","volume":"57","author":"BY Lu","year":"2016","unstructured":"Lu BY, Thanawala SU, Zochowski KC, Burke MJ, Carroll WL, Bhatla T . Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples. Leuk Lymphoma 2016; 57: 1938\u20131941.","journal-title":"Leuk Lymphoma"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2017191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2017191","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2017191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:20:06Z","timestamp":1648063206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2017191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFbmt2017191"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.191","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,11]]},"assertion":[{"value":"11 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}